Fourth Time’s The Charm? Teva Cites Colloids in Latest Attempt to Convince FDA to Require Clinical Trials for Generic Copaxone

FDA has rejected three previous citizen petitions from Teva seeking to impose barriers on future generic filers for the MS drug.